Literature DB >> 15300330

Liver stage antigen and malaria.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15300330     DOI： 10.1007/s00109-004-0572-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  4 in total

1.  Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

Authors:  P Daubersies; A W Thomas; P Millet; K Brahimi; J A Langermans; B Ollomo; L BenMohamed; B Slierendregt; W Eling; A Van Belkum; G Dubreuil; J F Meis; C Guérin-Marchand; S Cayphas; J Cohen; H Gras-Masse; P Druilhe; L B Mohamed
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

Review 2.  Malaria vaccine developments.

Authors:  Vasee S Moorthy; Michael F Good; Adrian V S Hill
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

3.  Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells.

Authors:  Javier E García; Hernando Curtidor; Ramses López; Luis Rodríguez; Ricardo Vera; John Valbuena; Jaiver Rosas; Marisol Ocampo; Alvaro Puentes; Martha Forero; Manuel A Patarroyo; Manuel Elkin Patarroyo
Journal:  J Mol Med (Berl)       Date:  2004-08-07       Impact factor: 4.599

4.  A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

Authors:  Eric Prieur; Sarah C Gilbert; Joerg Schneider; Anne C Moore; Eric G Sheu; Nilu Goonetilleke; Kathryn J H Robson; Adrian V S Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.